Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonradiographic Axial Spondyloarthritis”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Study completedNCT03928704
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis

Who this might be right for
Nonradiographic Axial Spondyloarthritis
UCB Biopharma SRL 274
Not applicableStudy completedNCT04706650
What this trial is testing

Exercise Capacity, Cardiovascular Risk Factors and Disease-related Variables in Axial Spondyloarthritis

Who this might be right for
Exercise CapacityAxial Spondyloarthritis
Muğla Sıtkı Koçman University 76
Large-scale testing (Phase 3)Study completedNCT02552212
What this trial is testing

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

Who this might be right for
Axial SpondyloarthritisNonradiographic Axial SpondyloarthritisNr-axSpA
UCB BIOSCIENCES GmbH 317
Large-scale testing (Phase 3)Ended earlyNCT02407223
What this trial is testing

An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis

Who this might be right for
Nonradiographic Axial Spondylitis, Ankylosing
Janssen Research & Development, LLC 356
Large-scale testing (Phase 3)Study completedNCT02757352
What this trial is testing

Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis

Who this might be right for
Axial Spondyloarthritis
Eli Lilly and Company 303
Large-scale testing (Phase 3)Active Not RecruitingNCT04436640
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Who this might be right for
Axial SpondyloarthritisAnkylosing Spondylitisr-axSpa+1 more
UCB Biopharma SRL 508